About the Campaign
“Screen at 23” seeks to do what it says: get every Asian American patient with a body mass index of 23 or higher screened for diabetes. This requires educating providers who previously might rule out diabetes as a risk factor for an Asian who is “skinny” or “average” in build. It requires educating the public that having a BMI of 23 is not a new definition of “overweight” or “obesity” for Asian Americans, but rather a number to look out for, one that should have individuals thinking about making healthy changes to their diet and incorporating healthy changes to their lifestyle, such as exercising. Above all, the campaign seeks to unmask diabetes and prediabetes in Asian Americans.
Campaign Organizer: NCAPIP
The National Council of Asian Pacific Islander Physicians (NCAPIP) is a nonprofit organization of physicians working towards eliminating health disparities in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) patients. NCAPIP members are comprised of leaders in national, state, and local physician organizations and medical groups. They are physicians practicing across a wide variety of settings from small and solo private practices, medical groups, community health centers, private and public hospitals, academic health centers, and state and local health departments. Their experience across all levels of medicine, care, and knowledge of the population makes NCAPIP an organization uniquely capable to advocate for the health of AANHPIs.
NCAPIP acts as a bridge between physicians, patients, and health policy makers.
In 2011, NCAPIP organized diabetes symposium in Hawaii with the support of the American Diabetes Association and Joslin Diabetes Center. This led to the formation of the AANHPI Diabetes Coalition, a coalition of organizations and individuals dedicated to alleviating and eliminating the diabetes disparities in AANHPI communities. NCAPIP has coordinated the Coalition since 2011, pushed the Coalition’s agenda forward, and created the “Screen at 23” campaign to raise awareness of the need to screen Asian Americans for diabetes at a lower body mass index.
Leaders within the AANHPI Diabetes Coalition are some of the foremost experts in diabetes research among AANHPI, and their research has been the foundation that the ADA guidelines are based on. The “Screen at 23” campaign is a reflection of their work.
The Asian American Diabetes Initiative (AADI) at Joslin Diabetes Center, (affiliated with Harvard Medical School) is a founding partner of the AANPI Diabetes Coalition. AADI conducts and publishes some of the leading research on diabetes among AANHPI populations, including the foundational studies that led to the formation of the “Screen at 23” campaign. Joslin AADI is committed to turning good research into good action, and has supported the Coalition with funding, guidance, and leadership over the past four years.
The American Diabetes Association (ADA) is the world’s largest organization dedicated to eliminating diabetes. In January 2015, the Association changed its Standards of Medical Care in Diabetes to reflect the need to screen Asian Americans at a body mass index of 23. The Association has focused on diabetes among minority populations through efforts such as our Diabetes Disparities Action Councils which focuses on advocating for the needs of higher risk communities, and in 2011 helped form the AANHPI Diabetes Coalition to push forward initiatives focused on diabetes in AANHPIs. The Association has provided guidance and crucial funding support to the AANHPI Diabetes Coalition, including funding the “Screen at 23” campaign website.
The Association is committed to addressing diabetes disparities and advocating for health equity.